定量与定性超声特征分析预测三阴性乳腺癌病理及免疫组化特征的表现比较
该研究回顾性分析252例女性三阴性乳腺癌患者的超声图像及临床病理免疫组化数据,比较定性BI-RADS特征与高通量定量影像组学特征预测组织学分级、Ki67、HER2、腋窝淋巴结转移及脉管侵犯的性能,结果显示定量特征AUC更高。
要点
- 三阴性乳腺癌超声表现多样,形态规则、无毛刺、后方回声增强、无钙化是其独立超声特征。
- 定性超声特征预测组织学分级、Ki67、HER2、腋窝淋巴结转移及脉管侵犯的AUC分别为0.673、0.680、0.651、0.587、0.566。
- 定量高通量影像组学特征预测上述生物学行为的AUC分别为0.942、0.732、0.730、0.804、0.795,优于定性特征。
核心结论
- 高通量定量超声特征在预测三阴性乳腺癌生物学行为方面优于传统定性超声特征。
研究设计与样本
- 回顾性研究,纳入252例女性三阴性乳腺癌患者的超声图像、临床、病理及免疫组化数据。
- 定性评估依据BI-RADS包括形态、边缘、后方回声模式及钙化。
- 定量分析基于计算机辅助影像组学,手动分割肿块后每幅图像提取7类共1688个影像组学特征。
- 采用主成分分析、LASSO及支持向量机筛选与生物学特性高度相关的特征,以AUC评价预测性能。
关键影像表现/征象
- 三阴性乳腺癌超声表现多样,与其生物学及临床特征相关。
- 定性评估中,形态规则、无成角或毛刺边缘、后方回声增强、无钙化为三阴性乳腺癌的独立超声特征。
诊断标准与关键数值
- 定性特征联合预测组织学分级、Ki67、HER2、腋窝淋巴结转移及脉管侵犯的AUC分别为0.673、0.680、0.651、0.587、0.566。
- 与生物学特性密切相关的定量特征数量:组织学分级34个(AUC 0.942)、Ki67 27个(AUC 0.732)、HER2 25个(AUC 0.730)、腋窝淋巴结转移34个(AUC 0.804)、脉管侵犯34个(AUC 0.795)。
临床应用与阅片要点
- 日常阅片可关注三阴性乳腺癌的形态规则、无毛刺边缘、后方回声增强及无钙化等定性特征。
- 定量影像组学特征在预测组织学分级、腋窝淋巴结转移及脉管侵犯方面AUC较高,有潜力辅助术前评估。
局限性
- 回顾性研究设计。
- 单中心样本。
- 未报告外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Sonographic features are associated with pathological and immunohistochemical characteristics of triple-negative breast cancer (TNBC). To predict the biological property of TNBC, the performance using quantitative high-throughput sonographic feature analysis was compared with that using qualitative feature assessment.
METHODS: We retrospectively reviewed ultrasound images, clinical, pathological, and immunohistochemical (IHC) data of 252 female TNBC patients. All patients were subgrouped according to the histological grade, Ki67 expression level, and human epidermal growth factor receptor 2 (HER2) score. Qualitative sonographic feature assessment included shape, margin, posterior acoustic pattern, and calcification referring to the Breast Imaging Reporting and Data System (BI-RADS). Quantitative sonographic features were acquired based on the computer-aided radiomics analysis. Breast cancer masses were manually segmented from the surrounding breast tissues. For each ultrasound image, 1688 radiomics features of 7 feature classes were extracted. The principal component analysis (PCA), least absolute shrinkage and selection operator (LASSO), and support vector machine (SVM) were used to determine the high-throughput radiomics features that were highly correlated to biological properties. The performance using both quantitative and qualitative sonographic features to predict biological properties of TNBC was represented by the area under the receiver operating characteristic curve (AUC).
RESULTS: In the qualitative assessment, regular tumor shape, no angular or spiculated margin, posterior acoustic enhancement, and no calcification were used as the independent sonographic features for TNBC. Using the combination of these four features to predict the histological grade, Ki67, HER2, axillary lymph node metastasis (ALNM), and lymphovascular invasion (LVI), the AUC was 0.673, 0.680, 0.651, 0.587, and 0.566, respectively. The number of high-throughput features that closely correlated with biological properties was 34 for histological grade (AUC 0.942), 27 for Ki67 (AUC 0.732), 25 for HER2 (AUC 0.730), 34 for ALNM (AUC 0.804), and 34 for LVI (AUC 0.795).
CONCLUSION: High-throughput quantitative sonographic features are superior to traditional qualitative ultrasound features in predicting the biological behavior of TNBC.
KEY POINTS: • Sonographic appearances of TNBCs showed a great variety in accordance with its biological and clinical characteristics. • Both qualitative and quantitative sonographic features of TNBCs are associated with tumor biological characteristics. • The quantitative high-throughput feature analysis is superior to two-dimensional sonographic feature assessment in predicting tumor biological property.
引用
- Li JW, Cao YC, Zhao ZJ, et al. Prediction for pathological and immunohistochemical characteristics of triple-negative invasive breast carcinomas: the performance comparison between quantitative and qualitative sonographic feature analysis. Eur Radiol. 2021. PMID: 34519862. doi:10.1007/s00330-021-08224-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。